Associations between febrile neutropenia-related parameters and the risk of acute GVHD or non-relapse mortality after allogeneic hematopoietic stem cell transplantation

scientific article published on 31 August 2018

Associations between febrile neutropenia-related parameters and the risk of acute GVHD or non-relapse mortality after allogeneic hematopoietic stem cell transplantation is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/S41409-018-0330-2
P698PubMed publication ID30171223

P50authorKazuaki KamedaQ86108563
Jin HayakawaQ91254523
Yu AkahoshiQ38641929
Kana SakamotoQ59684858
P2093author name stringMachiko Kusuda
Ayumi Gomyo
Hideki Nakasone
Hidenori Wada
Kiriko Terasako-Saito
Koji Kawamura
Miki Sato
Misato Kikuchi
Shinichi Kako
Shun-Ichi Kimura
Tomotaka Ugai
Yoshinobu Kanda
Yuko Ishihara
Kazuki Yoshimura
Aki Tanihara
Masaharu Tamaki
Yukiko Misaki
P2860cites workClinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donorsQ70051817
Regimen-related toxicity in patients undergoing bone marrow transplantationQ70215525
Feasibility and response to budesonide as topical corticosteroid therapy for acute intestinal GVHDQ73372633
Acute graft-versus-host disease does not require alloantigen expression on host epitheliumQ74221421
Preengraftment serum C-reactive protein (CRP) value may predict acute graft-versus-host disease and nonrelapse mortality after allogeneic hematopoietic stem cell transplantationQ81079571
Early elevation of C-reactive protein correlates with severe infection and nonrelapse mortality in children undergoing allogeneic stem cell transplantationQ82224325
Evaluation of C-reactive protein, interleukin-6, and procalcitonin levels in allogeneic hematopoietic stem cell recipientsQ82231770
Patterns of C-reactive protein release following allogeneic stem cell transplantation are correlated with leukemic relapseQ82363808
Diagnosis and management of acute graft-versus-host diseaseQ83992372
Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantationQ33718837
Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemiaQ33857573
Reciprocal interactions of the intestinal microbiota and immune system.Q34033579
Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of americaQ34160380
Engraftment syndrome following hematopoietic stem cell transplantationQ34298239
Blood stream infection (BSI) and acute GVHD after hematopoietic SCT (HSCT) are associatedQ34626390
How I treat refractory acute GVHD.Q35828633
Microbiota Disruption Induced by Early Use of Broad-Spectrum Antibiotics Is an Independent Risk Factor of Outcome after Allogeneic Stem Cell Transplantation.Q36289007
Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host diseaseQ36357597
Cytokine profiles as markers of disease severity in sepsis: a multiplex analysisQ36392617
Interleukin-6 and the acute phase responseQ36559880
How I treat acute graft-versus-host disease of the gastrointestinal tract and the liver.Q36727862
Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival.Q36835126
Plasma elevations of tumor necrosis factor-receptor-1 at day 7 postallogeneic transplant correlate with graft-versus-host disease severity and overall survival in pediatric patientsQ36961081
Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease.Q37152028
Pro-inflammatory mechanisms in sepsisQ37887361
The role of the immune system in governing host-microbe interactions in the intestineQ38115440
Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality.Q38483410
The Role of Biomarkers in the Diagnosis and Risk Stratification of Acute Graft-versus-Host Disease: A Systematic ReviewQ38829335
Antibiotic-Induced Depletion of Anti-inflammatory Clostridia Is Associated with the Development of Graft-versus-Host Disease in Pediatric Stem Cell Transplantation PatientsQ38964217
High Incidence of Afebrile Bloodstream Infection Detected by Surveillance Blood Culture in Patients on Corticosteroid Therapy after Allogeneic Hematopoietic Stem Cell Transplantation.Q40137330
The influence of gut-decontamination prophylactic antibiotics on acute graft-versus-host disease and survival following allogeneic hematopoietic stem cell transplantationQ40333157
Evaluation of procalcitonin, neopterin, C-reactive protein, IL-6 and IL-8 as a diagnostic marker of infection in patients with febrile neutropenia.Q40413348
Investigation of the freely available easy-to-use software 'EZR' for medical statisticsQ41513106
Elevations of tumor necrosis factor receptor 1 at day 7 and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioningQ43198292
Pre-engraftment blood stream infection is a risk factor for acute GVHD grades II-IV.Q43789729
Cyclooxygenase-2 is induced in brain blood vessels during fever evoked by peripheral or central administration of tumor necrosis factorQ48462356
Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of α-defensins.Q51169431
Safety of avoiding systemic corticosteroid administration for grade II acute graft-versus-host disease limited to the skin.Q51780256
Neural Mechanisms of Inflammation-Induced FeverQ58314745
P433issue5
P304page(s)707-716
P577publication date2018-08-31
P1433published inBone Marrow TransplantationQ4941523
P1476titleAssociations between febrile neutropenia-related parameters and the risk of acute GVHD or non-relapse mortality after allogeneic hematopoietic stem cell transplantation
P478volume54

Search more.